No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Alterity Therapeutics Receives US FDA Fast Track Designation; Shares Up 11%
Alterity Wins FDA Fast-track for ATH434 – but With 9B Shares on Issue, Impact Diluted
Alterity Completes Neurogenerative Disease Trial
Alterity Therapeutics Ltd: Half Yearly Report and Accounts
Alterity Therapeutics Raises About AU$2.1 Million Via US Facility; Shares Soar 17%
Alterity Therapeutics (ASX:ATH) Shareholder Returns Have Been Stellar, Earning 260% in 1 Year